{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-24-090121","form_type":"8-K","ticker":"IXHL","cik":"0001873875","company_name":"Incannex Healthcare Inc.","filed_at":"2024-10-24T23:59:59+00:00","discovered_at":"2026-05-14T18:03:10.208206+00:00","generated_at":"2026-05-30T10:39:04.957253+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"confidence":"high","headline":"Incannex appoints Dr. Luigi Barbato as CMO; base salary $375K, RSU grant of 100,476 shares vesting over 3 years","bullets":["Dr. Barbato appointed Chief Medical Officer effective October 21, 2024; reports to CEO Joel Latham.","Base salary of $375,000 with target annual incentive up to 20% of base salary.","Granted 100,476 restricted stock units (approx. $200K / 5-day VWAP) vesting in 3 equal annual installments.","Most recently Global Medical Lead at Jazz Pharmaceuticals; prior roles at AbbVie, Biogen, Novartis."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-24-090121","json":"https://secwatch.observer/filing/0001213900-24-090121.json","markdown":"https://secwatch.observer/filing/0001213900-24-090121.md","text":"https://secwatch.observer/filing/0001213900-24-090121.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1873875/000121390024090121/0001213900-24-090121-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1873875/000121390024090121/ea0218506-8k_incannex.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-30T10:39:04.957253+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"84e9ad37ae","claim":"Luigi M. Barbato, M.D. was appointed as Chief Medical Officer at Incannex Healthcare Inc..","evidence_excerpt":"Effective October 21, 2024 (the “Effective Date”), Incannex Healthcare Inc. (the “Company”) entered into an employment agreement (the “Employment Agreement”) with Luigi M. Barbato, M.D., to serve as the Company’s Chief Medical Officer.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1873875/000121390024090121/0001213900-24-090121-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Chief Medical Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}